MeSH term
Frequency | Condition_Probility | Adult | 9 | 0.0 |
Comparative Study | 7 | 0.0 |
Humans | 58 | 0.0 |
3T3 Cells | 7 | 0.0 |
Animals | 28 | 0.0 |
Binding Sites | 6 | 0.0 |
Binding, Competitive | 2 | 0.0 |
Blotting, Western | 2 | 0.0 |
Cell Line | 13 | 0.0 |
Chromosome Mapping | 5 | 0.0 |
*DNA-Binding Proteins | 2 | 0.0 |
Gene Expression | 6 | 0.0 |
Immunohistochemistry | 11 | 0.0 |
Mice | 15 | 0.0 |
Mutagenesis, Site-Directed | 4 | 0.0 |
Promoter Regions (Genetics) | 3 | 0.0 |
Rats | 10 | 0.0 |
Receptors, Fibroblast Growth Factor/*genetics | 9 | 3.0 |
Research Support, Non-U.S. Gov't | 46 | 0.0 |
Transfection | 7 | 0.0 |
Tumor Cells, Cultured | 8 | 0.0 |
Amino Acid Sequence | 12 | 0.0 |
Genotype | 2 | 0.0 |
Molecular Sequence Data | 17 | 0.0 |
Receptors, Fibroblast Growth Factor/biosynthesis/*genetics | 3 | 27.0 |
Base Sequence | 12 | 0.0 |
Mice, Nude | 2 | 0.0 |
Phosphorylation | 3 | 0.0 |
Protein Isoforms/genetics/metabolism | 2 | 1.0 |
Receptors, Fibroblast Growth Factor/*genetics/*metabolism | 2 | 11.0 |
Adolescent | 3 | 0.0 |
Aged | 8 | 0.0 |
Aged, 80 and over | 4 | 0.0 |
Female | 18 | 0.0 |
Male | 12 | 0.0 |
Middle Aged | 7 | 0.0 |
*Protein-Tyrosine Kinase | 6 | 1.0 |
Receptor Protein-Tyrosine Kinases/metabolism | 3 | 1.0 |
Receptors, Fibroblast Growth Factor/*metabolism | 5 | 9.0 |
Tissue Distribution | 3 | 0.0 |
Cell Division | 4 | 0.0 |
Dose-Response Relationship, Drug | 2 | 0.0 |
Enzyme-Linked Immunosorbent Assay | 2 | 0.0 |
Protein Binding | 2 | 0.0 |
Protein Structure, Secondary | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 12 | 0.0 |
Mice, Inbred BALB C | 2 | 0.0 |
Neoplasm Invasiveness | 3 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 5 | 0.0 |
Recombinant Proteins/chemistry/metabolism | 3 | 0.0 |
In Situ Hybridization | 4 | 0.0 |
Protein Structure, Tertiary | 2 | 0.0 |
DNA-Binding Proteins/*metabolism | 3 | 0.0 |
Receptors, Fibroblast Growth Factor/genetics/*metabolism | 5 | 14.0 |
Acrocephalosyndactylia/genetics | 2 | 15.0 |
Signal Transduction/genetics | 2 | 0.0 |
Alternative Splicing | 3 | 0.0 |
Receptors, Fibroblast Growth Factor | 3 | 13.0 |
Signal Transduction/*physiology | 2 | 0.0 |
RNA, Messenger/analysis | 2 | 0.0 |
Receptor Protein-Tyrosine Kinases/genetics/metabolism | 2 | 3.0 |
Cross-Linking Reagents | 2 | 0.0 |
Cytoskeleton/metabolism | 2 | 0.0 |
Fibroblast Growth Factor 1/*metabolism | 2 | 18.0 |
Fluorescent Antibody Technique | 2 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
Phylogeny | 2 | 0.0 |
RNA, Messenger/analysis/genetics | 2 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Fibroblast Growth Factors | 3 | 21.0 |
Polymorphism, Restriction Fragment Length | 2 | 0.0 |
Prognosis | 2 | 0.0 |
Survival Analysis | 2 | 0.0 |
*Chromosomes, Human, Pair 5 | 6 | 2.0 |
Pedigree | 5 | 0.0 |
*Chromosome Mapping | 2 | 0.0 |
Haplotypes | 2 | 0.0 |
Software | 2 | 0.0 |
Fibroblast Growth Factors/metabolism | 2 | 3.0 |
Receptors, Fibroblast Growth Factor/analysis | 2 | 12.0 |
Child | 3 | 0.0 |
Polymerase Chain Reaction | 5 | 0.0 |
Sequence Homology, Amino Acid | 4 | 0.0 |
Electrophoresis, Gel, Pulsed-Field | 2 | 0.0 |
Exons | 2 | 0.0 |
Introns | 2 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
*Fibroblast Growth Factors | 3 | 3.0 |
Cell Nucleus/metabolism | 2 | 0.0 |
*Receptor Protein-Tyrosine Kinases | 2 | 3.0 |
Gene Expression Profiling | 3 | 0.0 |
Sequence Homology, Nucleic Acid | 4 | 0.0 |
Proto-Oncogene Proteins/genetics | 2 | 0.0 |
Blotting, Northern | 3 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
Cells, Cultured | 4 | 0.0 |
Receptors, Fibroblast Growth Factor/genetics/metabolism | 2 | 8.0 |
DNA Primers | 3 | 0.0 |
In Situ Hybridization, Fluorescence | 2 | 0.0 |
Translocation, Genetic | 2 | 0.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Receptors, Cell Surface/*genetics | 2 | 0.0 |
Pituitary Neoplasms/*metabolism/pathology | 2 | 15.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
